SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the
BEIJING,Feb. 25,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"),a leading AI company with strong Internet foundation,today announced that Baid
SINGAPORE,Feb. 25,2025-- China Yuchai International Limited(NYSE: CYD) ("China Yuchai" or the "Company"),one of the largest powertrain solution manufacturers through its main opera
KARACHI,Pakistan,Feb. 25,2025--Kerry,a global leader in taste and nutrition,has partnered with Far Eastern Impex (FEI) to open the first international production operation for flavourings in Pakistan
SHENZHEN,China,Feb. 25,2025--Pudu Robotics,a global leader in service robotics,is revolutionizing cleanliness standards at Ryugujo Spa Hotel Mikazuki Ryugutei in Japan,a renowned Japanese hot spring
SHANGHAI,Feb. 25,2025-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm
SHANGHAI,Feb. 25,2025-- WuXi XDC Cayman Inc. ("WuXi XDC",or the "Company",stock code: 2268.HK),a leading global CRDMO (Contract Research,Development,and Manufacturing Organization)
-Earnings Webinar Scheduled for 6:00 a.m. ET on March 18,2025- GUANGZHOU,China,Feb. 25,2025--HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA),a leading game live streaming platform
ABU DHABI,UAE,Feb. 25,2025--teamLab Phenomena Abu Dhabiwill officially open its doors to the public in Saadiyat Cultural District Abu Dhabi on 18 April 2025,announced by the Department of Culture and
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned